The prognosis and durable clearance of RAS mutations in patients with acute myeloid leukemia receiving induction chemotherapy. uri icon

Overview

publication date

  • March 24, 2021

Research

keywords

  • Antineoplastic Combined Chemotherapy Protocols
  • Gain of Function Mutation
  • Genes, ras
  • Induction Chemotherapy
  • Leukemia, Myeloid, Acute
  • Mutation

Identity

PubMed Central ID

  • PMC8335797

Scopus Document Identifier

  • 85102933035

Digital Object Identifier (DOI)

  • 10.1002/ajh.26146

PubMed ID

  • 33650111

Additional Document Info

volume

  • 96

issue

  • 5